HEALTH

Natural Products Association names Jim LaValle Clinician of the Year

BY Allison Cerra

CINCINNATI — The Natural Products Association has named Jim LaValle as one of its 2011 Clinician of the Year award recipients.

As previously reported by Drug Store News, LaValle will receive his award at the Natural Products Association MarketPlace in Las Vegas next month. He is an educator, clinician and founder of the LaValle Metabolic Institute, as well as the founder of Integrative Health Resources, a natural products industry consulting company. He has been integrating natural therapies into various medical and business models for 27 years.

“In considering you for this award, we considered the breadth of your work in the field of integrative health care,” said John Gay, executive director and CEO of the Natural Products Association. “Congratulations on this honor.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

MusclePharm’s supplement to receive L-box placement at GNC stores

BY Allison Cerra

DENVER — MusclePharm’s MuscleGel product this summer will receive premier placement in GNC stores, MusclePharm announced.

The company’s MuscleGel nutritional supplement, which is a gel-based formula that touts 22 g of protein and 96 calories in each pack, will be showcased in an L-box placement at each GNC location. L-box placement is reserved for top-selling companies and products, MusclePharm said.

"This is a great sign that our relationship with GNC is getting stronger by the day. We had an incredible first quarter of 2011, and we are looking forward to even bigger things with them for the rest of 2011 and 2012," MusclePharm CEO Brad Pyatt said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Allegra captures strong sales

BY Michael Johnsen

PARIS — Sanofi-Aventis on Thursday reported strong sales out of the gate for its recently switched second-generation antihistamine Allegra.

Allegra generated in excess of $26.7 million within its first month available as a nonprescription allergy treatment in the U.S. market, becoming No. 2 in terms of dollar share of allergy, the company reported.

First-quarter sales of Sanofi’s Consumer Health Care totaled $1.1 billion, representing an increase of 40.3%.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?